Enhabit, Inc Reports Strong Q3 2025 Financial Results

Enhabit, Inc ( (EHAB) ) just unveiled an update.

Enhabit, Inc. reported its third-quarter 2025 financial results, highlighting a year-over-year increase in revenue, census, and Adjusted EBITDA, which enabled a reduction in bank debt and strengthening of its balance sheet. The company achieved a net service revenue of $263.6 million, with significant growth in hospice services and a strategic focus on reducing costs and improving operational efficiency. The results reflect Enhabit’s ability to stabilize its Medicare average daily census and expand its non-Medicare admissions, contributing to its improved financial performance and industry positioning.

The most recent analyst rating on (EHAB) stock is a Hold with a $8.50 price target. To see the full list of analyst forecasts on Enhabit, Inc stock, see the EHAB Stock Forecast page.

Spark’s Take on EHAB Stock

According to Spark, TipRanks’ AI Analyst, EHAB is a Neutral.

Enhabit, Inc.’s overall stock score is primarily influenced by its financial performance challenges, including declining revenues and profitability issues. The earnings call provided some optimism with strategic initiatives and strong hospice segment growth, but regulatory uncertainties and valuation concerns weigh heavily on the stock’s outlook.

To see Spark’s full report on EHAB stock, click here.

More about Enhabit, Inc

Enhabit, Inc. is a leading provider in the home health and hospice care industry, focusing on delivering comprehensive healthcare services to patients in their homes. The company is known for its strategic initiatives aimed at growth and financial stability, with a market focus on both Medicare and non-Medicare admissions.

Average Trading Volume: 407,629

Technical Sentiment Signal: Sell

Current Market Cap: $413.1M

For a thorough assessment of EHAB stock, go to TipRanks’ Stock Analysis page.